PROK
Price
$2.57
Change
+$0.07 (+2.80%)
Updated
Dec 24 closing price
Capitalization
363.77M
Intraday BUY SELL Signals
SABS
Price
$3.84
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Capitalization
182.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

PROK vs SABS

Header iconPROK vs SABS Comparison
Open Charts PROK vs SABSBanner chart's image
ProKidney
Price$2.57
Change+$0.07 (+2.80%)
Volume$409.25K
Capitalization363.77M
SAB Biotherapeutics
Price$3.84
Change-$0.00 (-0.00%)
Volume$55.78K
Capitalization182.81M
PROK vs SABS Comparison Chart in %
PROK
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PROK vs. SABS commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROK is a Buy and SABS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (PROK: $2.57 vs. SABS: $3.84)
Brand notoriety: PROK and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PROK: 28% vs. SABS: 20%
Market capitalization -- PROK: $363.77M vs. SABS: $182.81M
PROK [@Biotechnology] is valued at $363.77M. SABS’s [@Biotechnology] market capitalization is $182.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PROK’s FA Score shows that 0 FA rating(s) are green whileSABS’s FA Score has 0 green FA rating(s).

  • PROK’s FA Score: 0 green, 5 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, SABS is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PROK’s TA Score shows that 4 TA indicator(s) are bullish while SABS’s TA Score has 4 bullish TA indicator(s).

  • PROK’s TA Score: 4 bullish, 4 bearish.
  • SABS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both PROK and SABS are a good buy in the short-term.

Price Growth

PROK (@Biotechnology) experienced а +9.36% price change this week, while SABS (@Biotechnology) price change was -3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($364M) has a higher market cap than SABS($183M). PROK YTD gains are higher at: 52.071 vs. SABS (1.207). SABS has higher annual earnings (EBITDA): 22.1M vs. PROK (-149.22M). PROK has more cash in the bank: 272M vs. SABS (111M). PROK has less debt than SABS: PROK (4.24M) vs SABS (6.19M). PROK has higher revenues than SABS: PROK (744K) vs SABS (0).
PROKSABSPROK / SABS
Capitalization364M183M199%
EBITDA-149.22M22.1M-675%
Gain YTD52.0711.2074,314%
P/E RatioN/AN/A-
Revenue744K0-
Total Cash272M111M245%
Total Debt4.24M6.19M68%
TECHNICAL ANALYSIS
Technical Analysis
PROKSABS
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
66%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
PROK
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGPHF0.13N/A
+3.54%
Northern Graphite Corp.
KOSCF36.51N/A
N/A
Kose Corp.
BRANF2.25N/A
N/A
Baran Group Ltd.
MXGBF45.32N/A
N/A
Molson Coors CDA Inc.
EADSY57.73-0.19
-0.33%
Airbus SE

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+2.80%
RLYB - PROK
45%
Loosely correlated
-3.13%
NRIX - PROK
39%
Loosely correlated
+0.36%
APGE - PROK
38%
Loosely correlated
+1.02%
KYMR - PROK
37%
Loosely correlated
-0.48%
ZYME - PROK
37%
Loosely correlated
+0.26%
More